Table 2:

Distributions of gestational average urinary exposure biomarkers and serum hormone concentrations. All PAH concentrations have been corrected for specific gravity.

	N	25th	50th	75th	90th	95th	Max	Geo.Mean	Geo.SD	ICC (95% CI)
1-OH-NAP	659	97.5	191	375	820	1436	25299	504	3.08	0.39 (0.26, 0.50)
2-OH-NAP	659	2640	4253	7548	14021	20179	87689	6768	2.29	0.56 (0.46, 0.64)
1-OH-PYR	659	62.1	98.9	154	248	316	2231	132	2.01	0.49 (0.37, 0.58)
2-OH-FLU	659	54.1	76.9	115	168	244	1312	105	1.91	0.43 (0.30, 0.53)
1-OH-PHE	659	57.6	89.0	132	202	255	1667	113	1.97	0.52 (0.41, 0.60)
Σ2,3-OH-PHE	659	55.1	80.2	121	175	231	1465	104	1.86	0.40 (0.27, 0.51)
4-OH-PHE	659	10.0	14.9	22.4	34.9	50.8	349.9	21.1	1.92	0.19 (0.03, 0.33)
9-OH-PHE	659	8.38	11.7	19.4	38.0	57.6	967	20.9	2.07	0.21 (0.05, 0.34)
CRH (pg/mL)	658	21.6	57.8	96.7	131	161	243	65.5	2.51	0.63 (0.54, 0.70)
Estriol (mg/mL)	655	16.1	23.8	34.8	46.7	60.8	265	28.3	1.82	−0.17 (−0.38, 0.01)
Progesterone (ng/mL)	658	40.4	53.8	74.5	104	136	1037	65	1.67	0.09 (−0.09, 0.24)
Testosterone (pg/mL)	658	48.0	77.9	406	733	898	1496	246	3.33	0.75 (0.69, 0.80)
SHBG (pg/mL)	659	441	561	690	842	937	1404	582	1.44	0.77 (0.71, 0.81)
TSH (uIU/mL)	655	0.77	1.20	1.79	2.51	3.10	8.92	1.41	1.97	0.66 (0.58, 0.72)
T3 (mg/mL)	658	1.34	1.78	2.09	2.36	2.50	3.19	1.71	1.55	0.68 (0.61, 0.74)
fT4 (ng/dL)	658	0.93	1.03	1.13	1.21	1.28	1.72	1.03	1.18	0.55 (0.45, 0.64)
T4 (ug/dL)	655	10.5	11.8	13.2	14.4	15.2	19.0	11.9	1.19	0.76 (0.69, 0.80)